156 related articles for article (PubMed ID: 20460895)
1. Tolerance induction in response to liver inflammation.
Erhardt A; Tiegs G
Dig Dis; 2010; 28(1):86-92. PubMed ID: 20460895
[TBL] [Abstract][Full Text] [Related]
2. IL-10, regulatory T cells, and Kupffer cells mediate tolerance in concanavalin A-induced liver injury in mice.
Erhardt A; Biburger M; Papadopoulos T; Tiegs G
Hepatology; 2007 Feb; 45(2):475-85. PubMed ID: 17256743
[TBL] [Abstract][Full Text] [Related]
3. Tr1 regulatory T cells induced by ConA pretreatment prevent mice from ConA-induced hepatitis.
Ye F; Yan S; Xu L; Jiang Z; Liu N; Xiong S; Wang Y; Chu Y
Immunol Lett; 2009 Feb; 122(2):198-207. PubMed ID: 19200442
[TBL] [Abstract][Full Text] [Related]
4. CXCR3 deficiency exacerbates liver disease and abrogates tolerance in a mouse model of immune-mediated hepatitis.
Erhardt A; Wegscheid C; Claass B; Carambia A; Herkel J; Mittrücker HW; Panzer U; Tiegs G
J Immunol; 2011 May; 186(9):5284-93. PubMed ID: 21441449
[TBL] [Abstract][Full Text] [Related]
5. CCL3/MIP-1alpha is pro-inflammatory in murine T cell-mediated hepatitis by recruiting CCR1-expressing CD4(+) T cells to the liver.
Ajuebor MN; Hogaboam CM; Le T; Proudfoot AE; Swain MG
Eur J Immunol; 2004 Oct; 34(10):2907-18. PubMed ID: 15368307
[TBL] [Abstract][Full Text] [Related]
6. CD24 aggravates acute liver injury in autoimmune hepatitis by promoting IFN-γ production by CD4
Zheng C; Yin S; Yang Y; Yu Y; Xie X
Cell Mol Immunol; 2018 Mar; 15(3):260-271. PubMed ID: 28065940
[TBL] [Abstract][Full Text] [Related]
7. Retinoic acid modulates IL-4, IL-10 and MCP-1 pathways in immune mediated hepatitis and interrupts CD4+ T cells infiltration.
Elshal M; Abu-Elsaad N; El-Karef A; Ibrahim T
Int Immunopharmacol; 2019 Oct; 75():105808. PubMed ID: 31419710
[TBL] [Abstract][Full Text] [Related]
8. Favored T helper 1 response in a mouse model of hepatosteatosis is associated with enhanced T cell-mediated hepatitis.
Kremer M; Hines IN; Milton RJ; Wheeler MD
Hepatology; 2006 Jul; 44(1):216-27. PubMed ID: 16799967
[TBL] [Abstract][Full Text] [Related]
9. Role of myeloid-derived suppressor cells in amelioration of experimental autoimmune hepatitis following activation of TRPV1 receptors by cannabidiol.
Hegde VL; Nagarkatti PS; Nagarkatti M
PLoS One; 2011 Apr; 6(4):e18281. PubMed ID: 21483776
[TBL] [Abstract][Full Text] [Related]
10. Protective role of V-set and immunoglobulin domain-containing 4 expressed on kupffer cells during immune-mediated liver injury by inducing tolerance of liver T- and natural killer T-cells.
Jung K; Kang M; Park C; Hyun Choi Y; Jeon Y; Park SH; Seo SK; Jin D; Choi I
Hepatology; 2012 Nov; 56(5):1838-48. PubMed ID: 22711680
[TBL] [Abstract][Full Text] [Related]
11. Metformin aggravates immune-mediated liver injury in mice.
Volarevic V; Misirkic M; Vucicevic L; Paunovic V; Simovic Markovic B; Stojanovic M; Milovanovic M; Jakovljevic V; Micic D; Arsenijevic N; Trajkovic V; Lukic ML
Arch Toxicol; 2015 Mar; 89(3):437-50. PubMed ID: 24770553
[TBL] [Abstract][Full Text] [Related]
12. IFN-gamma/STAT1 acts as a proinflammatory signal in T cell-mediated hepatitis via induction of multiple chemokines and adhesion molecules: a critical role of IRF-1.
Jaruga B; Hong F; Kim WH; Gao B
Am J Physiol Gastrointest Liver Physiol; 2004 Nov; 287(5):G1044-52. PubMed ID: 15246962
[TBL] [Abstract][Full Text] [Related]
13. The role of intrahepatic CD8+ T cell trapping and NK1.1+ cells in liver-mediated immune regulation.
Shibolet O; Alper R; Zolotarov L; Trop S; Thalenfeld B; Engelhardt D; Rabbani E; Ilan Y
Clin Immunol; 2004 Apr; 111(1):82-92. PubMed ID: 15093555
[TBL] [Abstract][Full Text] [Related]
14. Cyclic adenosine monophosphate-responsive element modulator alpha overexpression impairs function of hepatic myeloid-derived suppressor cells and aggravates immune-mediated hepatitis in mice.
Hammerich L; Warzecha KT; Stefkova M; Bartneck M; Ohl K; Gassler N; Luedde T; Trautwein C; Tenbrock K; Tacke F
Hepatology; 2015 Mar; 61(3):990-1002. PubMed ID: 25330465
[TBL] [Abstract][Full Text] [Related]
15. Activation-induced NKT cell hyporesponsiveness protects from alpha-galactosylceramide hepatitis and is independent of active transregulatory factors.
Biburger M; Tiegs G
J Leukoc Biol; 2008 Jul; 84(1):264-79. PubMed ID: 18407967
[TBL] [Abstract][Full Text] [Related]
16. Salecan protected against concanavalin A-induced acute liver injury by modulating T cell immune responses and NMR-based metabolic profiles.
Sun Q; Xu X; Yang X; Weng D; Wang J; Zhang J
Toxicol Appl Pharmacol; 2017 Feb; 317():63-72. PubMed ID: 28109817
[TBL] [Abstract][Full Text] [Related]
17. Comparison of Concanavalin a-Induced Murine Autoimmune Hepatitis Models.
Ye T; Wang T; Yang X; Fan X; Wen M; Shen Y; Xi X; Men R; Yang L
Cell Physiol Biochem; 2018; 46(3):1241-1251. PubMed ID: 29672295
[TBL] [Abstract][Full Text] [Related]
18. Specific antibodies induced by DNA vaccination with extracellular domain of CD25 gene protect against ConA-induced autoimmune hepatitis.
Xu L; Zhang F; Xu W; Xiong S
Clin Immunol; 2009 Sep; 132(3):412-9. PubMed ID: 19501551
[TBL] [Abstract][Full Text] [Related]
19. Concanavalin a injection activates intrahepatic innate immune cells to provoke an antitumor effect in murine liver.
Miyagi T; Takehara T; Tatsumi T; Suzuki T; Jinushi M; Kanazawa Y; Hiramatsu N; Kanto T; Tsuji S; Hori M; Hayashi N
Hepatology; 2004 Nov; 40(5):1190-6. PubMed ID: 15486936
[TBL] [Abstract][Full Text] [Related]
20. (-)-Epigallocatechin-3-gallate protects mice from concanavalin A-induced hepatitis through suppressing immune-mediated liver injury.
Wang Y; Mei Y; Feng D; Xu L
Clin Exp Immunol; 2006 Sep; 145(3):485-92. PubMed ID: 16907918
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
